Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases
Yıl: 2023 Cilt: 57 Sayı: 2 Sayfa Aralığı: 257 - 262 Metin Dili: İngilizce DOI: 10.14744/SEMB.2023.77012 İndeks Tarihi: 11-07-2023
Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases
Öz: Objectives: Ultrasonography and fine-needle aspiration biopsy (FNAB) are the gold standard methods in the prediction of benign and malignant thyroid nodules. However, despite being easily applicable, FNAB is an invasive procedure. Less invasive biomarkers should be utilized in the diagnosis of thyroid malignancies. In this study, we aimed to determine the parameters that can be used in the diagnosis of differentiated thyroid cancer (DTC) based on the serum thyroid and thyroglobulin (TG) levels which are routinely checked in patients followed up for thyroid nodules. Methods: In the study, we evaluated patients who underwent thyroid surgery for nodular diseases between January 2015 and June 2022. Of the 1444 patients evaluated, 919 patients who met the inclusion criteria (normothyroid benign nodular disease or normothyroid DTC) were included in the study. Patients were divided into two groups as benign group (BG) and DTC group (DTCG). We compared patients’ pre-operative serum thyroid and TG values and the diagnostic properties of their ratios. Results: Of the 919 patients included, 517 (56.3%) were in BG and 402 (43.7%) were in DTCG. In DTCG, 318 patients were female and 84 patients were male. The mean age in the DTCG was 47.8 years. Comparison of DTCG and BG revealed a significant difference between T3/T4 ratio (p=0.002), T3/TSH ratio (p≤0.001), T4/TSH ratio (p≤0.001), TG/TSH ratio (p≤0.001), and TSH/TG ratio (p≤0.001). However, evaluation of the specified values by ROC analysis showed that the T3/T4 ratio did not make a significant difference be- tween the two groups (p=0.1), whereas the other values displayed a significant difference (p≤0.001 for T3/TSH, p=0.001 for T4/TSH, p≤0.001 for TG/TSH, and p<0.001 for TSH/TG). Conclusion: T3/TSH (cutoff =2.183), T4/TSH (cutoff=0.6), and TG/TSH (cutoff=29.67) values were found to be significant tumor markers for the prediction of malignancy in thyroid nodules, and low values were found to be associated with malignancy. TSH/TG (cutoff=0.031) value was also significant in predicting malignancy while high values were found to be associated with malignancy. Thyroid hormone and TG ratios may alter the preferred treatment method for thyroid nodules.
Anahtar Kelime: Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
- 1. Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer. Thyroid 2016;26:1-133. [CrossRef ]
- 2. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin 2020;70:7-30. [CrossRef ]
- 3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71:209-49. [CrossRef ]
- 4. Altiner S, Kozan R, Emral AC, Taneri F, Karamercan A. Effects of patient and tumor characteristics on central lymph node metastasis in papillary thyroid cancer: a guide for selective node dissection. Arch Iran Med 2022;25:730-6. [CrossRef ]
- 5. Demircioglu ZG, Aygun N, Demircioglu MK, Ozguven BY, Uludag M. Low vitamin D status is not associated with the aggressive pathological features of papillary thyroid cancer. Sisli Etfal Hastan Tip Bul 2022;56:132-6. [CrossRef ]
- 6. Aygün N, İşgör A, Uludağ M. Can active surveillance be an alternative to surgery in papillary thyroid microcarcinoma?: the current situation worldwide. Sisli Etfal Hastan Tip Bul 2018;52:233- 43. [CrossRef ]
- 7. Popoveniuc G, Jonklaas J. Thyroid nodules. Med Clin North Am 2012;96:329-49. [CrossRef ]
- 8. Cibas ES, Ali SZ. The 2017 Bethesda system for reporting thyroid cytopathology. Thyroid 2017;27:1341-6. [CrossRef ]
- 9. Yeung MJ, Serpell JW. Management of the solitary thyroid nodule. Oncologist 2008;13:105-12. [CrossRef ]
- 10. Coscia F, Taler-Verčič A, Chang VT, Sinn L, O'Reilly FJ, Izoré T, et al. The structure of human thyroglobulin. Nature 2020;578:627-30. [CrossRef ]
- 11. Yazici P, Mihmanli M, Bozkurt E, Ozturk FY, Uludag M. Which is the best predictor of thyroid cancer: thyrotropin, thyroglobulin or their ratio. Hormones (Athens) 2016;15:256-63. [CrossRef ]
- 12. Wang L, Li H, Yang Z, Guo Z, Zhang Q. Preoperative serum thyrotropin to thyroglobulin ratio is effective for thyroid nodule evaluation in euthyroid patients. Otolaryngol Head Neck Surg 2015;153:15-9. [CrossRef ]
- 13. Karvounis E, Kappas I, Angelousi A, Makris GM, Siamatras TD, Kassi E. The diagnostic and predictive accuracy of thyroglobulin to TSH ratio and TSH to thyroglobulin ratio in detecting differentiated thyroid carcinoma in normothyroid patients with thyroid nodules: a retrospective cohort study and systematic review of the literature. Oncol Rev 2020;14:439. [CrossRef ]
- 14. Haymart MR, Repplinger DJ, Leverson GE, Elson DF, Sippel RS, Jaume JC, et al. Higher serum thyroid stimulating hormone level in thyroid nodule patients is associated with greater risks of differentiated thyroid cancer and advanced tumor stage. J Clin Endocrinol Metab 2008;93:809-14. [CrossRef ]
- 15. Lee EK, Chung KW, Min HS, Kim TS, Kim TH, Ryu JS, et al. Preoperative serum thyroglobulin as a useful predictive marker to differentiate follicular thyroid cancer from benign nodules in indeterminate nodules. J Korean Med Sci 2012;27:1014-8. [CrossRef ]
- 16. Tam AA, Özdemir D, Aydın C, Bilginer MC, Yazıcıoğlu MÖ, Süngü N, et al. Ratio of thyrotropin to thyroglobulin as a novel marker for differentiating between benign and malignant thyroid nodules within different bethesda categories. Turk J Endocrinol Metab 2018;22:21-31. [CrossRef ]
APA | AYDOĞDU Y, Emreol U, Gülçek E, Büyükkasap Ç, Akın M (2023). Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. , 257 - 262. 10.14744/SEMB.2023.77012 |
Chicago | AYDOĞDU YUNUSHAN FURKAN,Emreol Umut İhsan,Gülçek Emre,Büyükkasap Çağrı,Akın Murat Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. (2023): 257 - 262. 10.14744/SEMB.2023.77012 |
MLA | AYDOĞDU YUNUSHAN FURKAN,Emreol Umut İhsan,Gülçek Emre,Büyükkasap Çağrı,Akın Murat Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. , 2023, ss.257 - 262. 10.14744/SEMB.2023.77012 |
AMA | AYDOĞDU Y,Emreol U,Gülçek E,Büyükkasap Ç,Akın M Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. . 2023; 257 - 262. 10.14744/SEMB.2023.77012 |
Vancouver | AYDOĞDU Y,Emreol U,Gülçek E,Büyükkasap Ç,Akın M Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. . 2023; 257 - 262. 10.14744/SEMB.2023.77012 |
IEEE | AYDOĞDU Y,Emreol U,Gülçek E,Büyükkasap Ç,Akın M "Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases." , ss.257 - 262, 2023. 10.14744/SEMB.2023.77012 |
ISNAD | AYDOĞDU, YUNUSHAN FURKAN vd. "Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases". (2023), 257-262. https://doi.org/10.14744/SEMB.2023.77012 |
APA | AYDOĞDU Y, Emreol U, Gülçek E, Büyükkasap Ç, Akın M (2023). Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. Şişli Etfal Hastanesi Tıp Bülteni, 57(2), 257 - 262. 10.14744/SEMB.2023.77012 |
Chicago | AYDOĞDU YUNUSHAN FURKAN,Emreol Umut İhsan,Gülçek Emre,Büyükkasap Çağrı,Akın Murat Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. Şişli Etfal Hastanesi Tıp Bülteni 57, no.2 (2023): 257 - 262. 10.14744/SEMB.2023.77012 |
MLA | AYDOĞDU YUNUSHAN FURKAN,Emreol Umut İhsan,Gülçek Emre,Büyükkasap Çağrı,Akın Murat Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. Şişli Etfal Hastanesi Tıp Bülteni, vol.57, no.2, 2023, ss.257 - 262. 10.14744/SEMB.2023.77012 |
AMA | AYDOĞDU Y,Emreol U,Gülçek E,Büyükkasap Ç,Akın M Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. Şişli Etfal Hastanesi Tıp Bülteni. 2023; 57(2): 257 - 262. 10.14744/SEMB.2023.77012 |
Vancouver | AYDOĞDU Y,Emreol U,Gülçek E,Büyükkasap Ç,Akın M Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases. Şişli Etfal Hastanesi Tıp Bülteni. 2023; 57(2): 257 - 262. 10.14744/SEMB.2023.77012 |
IEEE | AYDOĞDU Y,Emreol U,Gülçek E,Büyükkasap Ç,Akın M "Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases." Şişli Etfal Hastanesi Tıp Bülteni, 57, ss.257 - 262, 2023. 10.14744/SEMB.2023.77012 |
ISNAD | AYDOĞDU, YUNUSHAN FURKAN vd. "Determination of Diagnostic Features of Serum Thyroid Hormones and Thyroglobulin Ratios in Normothyroid Differentiated Thyroid Carcinoma Cases". Şişli Etfal Hastanesi Tıp Bülteni 57/2 (2023), 257-262. https://doi.org/10.14744/SEMB.2023.77012 |